Orlife Healthcare
Levosulpiride (75mg) + Rabeprazole (20mg)
Orabi-LS Capsule is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Capsule
Orabi-LS Capsule is a combination of two medicines: Levosulpiride and Rabeprazole. It reduces excess acid production in the stomach and prevents the reflux of stomach acid into the food pipe. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Take this medicine in the dose and duration as advised by your doctor. Orabi-LS Capsule is to be taken empty stomach.
Nausea Stomach pain Diarrhea Flatulence Constipation Headache Weakness Flu-like symptoms
It is unsafe to consume alcohol with Orabi-LS Capsule.
Information regarding the use of Orabi-LS Capsule during breastfeeding is not available. Please consult your doctor.
Orabi-LS Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Orabi-LS Capsule is a combination of two medicines: Levosulpiride and Rabeprazole.
Do not consume alcohol while taking Orabi-LS Capsule as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Orabi-LS Capsule for longer than prescribed.
Take Orabi-LS Capsule exactly as directed by your doctor. It is best to take one capsule daily on an empty stomach.
Avoid use of Orabi-LS Capsule if you have a known allergy to any component or excipient in the medication.
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) while using Orabi-LS Capsule. If you feel dizzy, rest for a few minutes and resume only when you feel better.
Some studies on adults suggest that treatment with Orabi-LS Capsule may be associated with an increased risk of osteoporosis-related hip, wrist, or spine fractures. The risk was higher in patients receiving high doses (multiple daily doses and long-term therapy – a year or more).
Orabi-LS Capsule may cause drowsiness, dizziness, or impairment of vision. Do not drive or operate machinery until you understand its effect on your body.
Store this medication in the original packaging, tightly closed. Follow the instructions on the label for proper storage. Do not consume leftover medication; it is unsafe for pets, children, or other individuals.